Literature DB >> 10900334

T cell recognition of muscle acetylcholine receptor in ocular myasthenia gravis.

Z Y Wang1, B Diethelm-Okita, D K Okita, H J Kaminski, J F Howard, B M Conti-Fine.   

Abstract

We examined the proliferative response of blood CD4(+) cells to muscle acetylcholine receptor (AChR) subunits and the epitope repertoire of the epsilon and gamma subunits, in ocular myasthenia gravis (oMG) patients and healthy subjects. oMG patients seldom recognized all subunits. The frequency and intensity of recognition was the same for all subunits, irrespective of the disease duration. The responses in oMG were lower than in generalized myasthenia gravis. Healthy subjects had frequent, low responses to one or more subunits. oMG patients recognized several epitopes on the gamma and epsilon subunits, that partially overlapped those recognized in gMG. The subunits and epitopes recognized by individual oMG patients changed over time. Thus, oMG patients have minimal and unstable sensitization of anti-AChR CD4(+) cells, in agreement with their low and inconsistent synthesis of anti-AChR antibody.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10900334     DOI: 10.1016/s0165-5728(00)00250-2

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  8 in total

Review 1.  Myasthenia gravis: past, present, and future.

Authors:  Bianca M Conti-Fine; Monica Milani; Henry J Kaminski
Journal:  J Clin Invest       Date:  2006-11       Impact factor: 14.808

Review 2.  Antibody Therapies in Autoimmune Neuromuscular Junction Disorders: Approach to Myasthenic Crisis and Chronic Management.

Authors:  Fiammetta Vanoli; Renato Mantegazza
Journal:  Neurotherapeutics       Date:  2022-02-14       Impact factor: 6.088

3.  Quantitation of anti-factor VIII antibodies in human plasma.

Authors:  Jolanta Krudysz-Amblo; Behnaz Parhami-Seren; Saulius Butenas; Kathleen E Brummel-Ziedins; Edward D Gomperts; Georges E Rivard; Kenneth G Mann
Journal:  Blood       Date:  2009-01-14       Impact factor: 22.113

4.  Modulation of B cell regulatory molecules CD22 and CD72 in myasthenia gravis and multiple sclerosis.

Authors:  Jiayin Lu; Jing Li; Tai-qing Zhu; Longbo Zhang; Yuzhong Wang; Fa-fa Tian; Huan Yang
Journal:  Inflammation       Date:  2013-06       Impact factor: 4.092

5.  Characterization of CD4 and CD8 T cell responses in MuSK myasthenia gravis.

Authors:  J S Yi; A Guidon; S Sparks; R Osborne; V C Juel; J M Massey; D B Sanders; K J Weinhold; J T Guptill
Journal:  J Autoimmun       Date:  2013-12-28       Impact factor: 7.094

6.  Autoreactive T Cells from Patients with Myasthenia Gravis Are Characterized by Elevated IL-17, IFN-γ, and GM-CSF and Diminished IL-10 Production.

Authors:  Yonghao Cao; Robert A Amezquita; Steven H Kleinstein; Panos Stathopoulos; Richard J Nowak; Kevin C O'Connor
Journal:  J Immunol       Date:  2016-01-29       Impact factor: 5.422

7.  Extraocular muscle characteristics related to myasthenia gravis susceptibility.

Authors:  Rui Liu; Hanpeng Xu; Guiping Wang; Jie Li; Lin Gou; Lihua Zhang; Jianting Miao; Zhuyi Li
Journal:  PLoS One       Date:  2013-02-08       Impact factor: 3.240

8.  A Sensitive Method for Detecting Peptide-specific CD4+ T Cell Responses in Peripheral Blood from Patients with Myasthenia Gravis.

Authors:  Sapna Sharma; Clas Malmeström; Christopher Lindberg; Sarah Meisel; Karin Schön; Martina Verolin; Nils Yngve Lycke
Journal:  Front Immunol       Date:  2017-10-24       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.